文献速递胃肠外科围术期管理与 ERAS

鞘内吗啡用于腹腔镜结直肠手术加速康复:一项随机临床试验

Intrathecal Morphine for Enhanced Recovery After Laparoscopic Colorectal Surgery: A Randomized Clinical Trial.
PubMed 文献 · JAMA Surg · 2026-01-01

该前瞻性双盲随机临床试验纳入252例择期腹腔镜结直肠手术成人患者,比较鞘内吗啡(3 µg/kg)与生理盐水安慰剂(均联合TAPB)对术后恢复质量的影响。结果显示鞘内吗啡组术后24小时QoR-15评分显著更高,阿片类药物消耗更少,恶心发生率更低,但瘙痒发生率更高。

要点

  • 鞘内吗啡3 µg/kg联合TAPB可显著改善腹腔镜结直肠手术后24小时恢复质量。
  • 鞘内吗啡减少术后阿片类药物累积消耗并降低恶心发生率。
  • 鞘内吗啡组瘙痒发生率明显升高,需纳入临床决策考量。

核心结论

  • 在腹腔镜结直肠手术中,鞘内吗啡联合TAPB可显著改善早期术后恢复和镇痛,但增加瘙痒风险。

研究设计与样本

  • 前瞻性、双盲随机临床试验,在中山大学肿瘤防治中心于2024年10月15日至2025年2月15日开展。
  • 成人择期腹腔镜结直肠手术患者按1:1随机接受鞘内吗啡或生理盐水安慰剂,两组均接受脂质体布比卡因TAPB作为ERAS方案的一部分。
  • 共252例患者纳入意向性治疗分析,平均(SD)年龄58.4(11.1)岁,女性112例(44.4%)。

主要发现

  • 术后24小时,干预组平均(SE)QoR-15评分显著高于对照组(114.95 [1.04] vs 102.22 [0.76];平均差12.21;95%CI 9.91-14.51;P < .001)。
  • 术后平均(SD)吗啡消耗量干预组低于对照组(4.4 [6.4] MME vs 10.4 [11.1] MME;平均差-6.59;95%CI -8.88至-4.31;P < .001)。
  • 干预组恶心发生率降低(23.8% vs 37.3%;调整风险差-15.06%;95%CI -26.60%至-3.52%;P = .01)。
  • 干预组瘙痒发生率升高(19.0% vs 3.2%;调整风险差15.08%;95%CI 7.26%-22.90%;P < .001)。

临床怎么用

  • 对于腹腔镜结直肠手术患者,可考虑鞘内吗啡3 µg/kg联合TAPB作为多模式镇痛方案的一部分以改善早期恢复。
  • 应用该策略时需警惕瘙痒风险增加,并做好相应监测与处理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Despite the recovery advantages of minimally invasive surgical techniques, moderate to severe pain after laparoscopic colorectal surgery is a common barrier to improving postoperative recovery quality. OBJECTIVE: To evaluate whether intrathecal morphine (ITM) combined with transversus abdominis plane block (TAPB) improves postoperative recovery quality after laparoscopic colorectal surgery. DESIGN, SETTING, AND PARTICIPANTS: This prospective, double-blind randomized clinical trial was conducted at Sun Yat-sen University Cancer Center between October 15, 2024, and February 15, 2025. Adults scheduled for elective laparoscopic colorectal surgery were randomized 1:1 to ITM or saline placebo. Data were analyzed from March 1, 2025, to March 31, 2025. INTERVENTIONS: Both groups received liposomal bupivacaine for TAPB as part of standard enhanced recovery after surgery (ERAS) protocol. The intervention group received ITM, 3 µg/kg, while the control group received intrathecal normal saline. MAIN OUTCOMES AND MEASURES: The primary outcome was the Quality of Recovery 15 (QoR-15) score at 24 hours postoperatively. Secondary outcomes included postoperative pain scores, cumulative opioid consumption (in morphine milligram equivalents [MME]), time to first flatus, time to first ambulation, incidence of adverse effects, and length of hospital stay. RESULTS: A total of 252 patients were included in the intention-to-treat analysis (mean [SD] age, 58.4 [11.1] years; 112 female patients [44.4%]). At 24 hours postoperatively, the intervention group had significantly higher mean (SE) QoR-15 scores compared to the control group (114.95 [1.04] vs 102.22 [0.76]; mean difference, 12.21; 95% CI, 9.91-14.51; P < .001), indicating better recovery quality. Postoperative mean (SD) morphine consumption was lower in the intervention group compared to the control group (4.4 [6.4] MME vs 10.4 [11.1] MME; mean difference, -6.59; 95% CI, -8.88 to -4.31; P < .001). The intervention group also had a reduced incidence of nausea (23.8% vs 37.3%; adjusted risk difference, -15.06%; 95% CI, -26.60% to -3.52%; P = .01), but a high incidence of pruritus was observed in the intervention group (19.0% vs 3.2%; adjusted risk difference, 15.08%; 95% CI, 7.26%-22.90%; P < .001). CONCLUSIONS AND RELEVANCE: Per the results of this randomized clinical trial, in laparoscopic colorectal surgery, ITM combined with TAPB can significantly enhance early postoperative recovery and analgesia, albeit with an increased risk of pruritus. This strategy may be a valuable component of multimodal analgesia regimens following laparoscopic colorectal surgery. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT06636864.

来源:JAMA Surg,查看原文。版权归原作者所有。

引用

  1. Zheng L, Lu Y, Lu X, et al. Intrathecal Morphine for Enhanced Recovery After Laparoscopic Colorectal Surgery: A Randomized Clinical Trial. JAMA Surg. 2026. PMID: 41433024. doi:10.1001/jamasurg.2025.5699

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。